Renal cancer accounts for nearly 2% of all cancers generally. The American Cancer Society expected about 36,160 new cases of kidney cancer in 2005. Over 80% of kidney cancers are renal cell carcinomas (RCC), and the rest are mainly renal pelvis cancers. Incidence ratio of death in RCC is higher compared with other urologic cancers. RCC is unpredictable even when diagnosed and treated early by nephrectomy. The neoplasm can remain constant for years and then metastasis to other body organs (
1). RCC is considered by absence of specific clinical signs. So it doesn’t allow the diagnosis at an early stage (
2). Therefore high percentage of patients will have metastasis at the first diagnosis and can’t be cured. Unfortunately, there is no effective treatment for metastatic renal cancer. Classic approaches to RCC, such as radiotherapy, chemotherapy, or hormone- therapy have little or even no effect on this cancer (
2). Immune-modulating agents, cytokines and differentiating agents, including retinoids, have shown antitumor activity in a low percentage of patients with metastatic RCC (
3-
5). These approaches don’t trace metastasis and even can stimulate tumor development by impairing the immune system. So, investigation of new approaches which focused on the regulation of tumor proliferation to effectively control RCC is necessary. Progress in the treatment of RCC has been little in the past 30 years and no effective chemotherapeutic agent presently is available against its (
6,
7). So, there is a need for new and more selective agents with ability to affect targets directly involved in the progression of RCC development. On the other hand, the biological heterogeneity of RCC, its resistance to chemotherapeutic agents, and the several side effects of chemotherapeutics are the major problems in the treatment of RCC. The rate of systemic metastasis in RCC is high with approximately 50% of the patients with developing metastasis after surgical resection. So, radical nephrectomy of localized RCC is effective only in a few patients (
8,
9). Therefore, the investigation for effective therapeutic agents for this cancer is urgently needed. Antioxidant-rich foods have many defensive properties against different diseases including neurologic degeneration, inflammatory disorders, coronary disease, and cancer (
10,
11).
Scutellaria L
. (Lamiaceae) is a genus that contains about 300 species in the world, excluding South Africa (
12).
Scutellaria L
. has 27 species and two hybrids in Iran. Among these 10 species and two hybrids are endemic to the country (
13,
14).
Scutellaria lindbergii Rech.f. is an Iranian species of this genus. Common distribution of this species is limited to Iran and Afghanistan (
14,
15). In folk medicine,
Scutellaria L
.as a flavonoid rich plant is used for treatment of several diseases. Many studies have shown various biological and pharmacological activities of some Scutellaria species including antibacterial (
16-
18), antiviral (
19), antifungal (
20), anti-inflammatory (
21), antioxidant (
22), cytotoxicity, and anticancer (
23-
25). Several researches have been carried out on some biological effects of
Scutellaria lindbergii including its antimicrobial, antioxidant (
26) and cytotoxic activities (
24). The genus
Ferula belongs to the family Apiaceae and has about 170 species. These are produced from central Asia westward to northern Africa (
27). The Iranian flora includes 30 species of Ferula that some of them are endemic (
28,
29). The common Persian name of the most species is “Koma”. Ferula have been explored chemically (
30-
32). The members of this genus are well known as a good source of biologically active compounds such as derivatives (
33-
35), and sulfur containing compounds (
36-
38).
F. gummosa was used astonic, anti-convulsant, anti-hysteric, decongestant and it is useful in treatment of neurological disorders, and stomachache (
39-
42). Umbelliferae comprises more than 450 genera and near 3700 species in the world (43). Kelussia is one of the most new genus of this family and is represented by only one species,
Kelussia odoratissima Mozaff. which is found only in Iran (
44). This sweet-smelling, self-growing monotypic medicinal plant is endemic to a limited area in western of Iran and is popularly called Karafse-Koohi. The aerial parts of the plant are usually used as a popular garnish and sedative. In traditional medicine,
K. odoratissima is consumed to treat hypertension, cardiovascular diseases, and inflammation ulcers (
45). The antioxidant properties of the methanolic extract of the plant were investigated by several methods.
Artemisia kopetdaghensis, aromatic shrubs belonging to the Asteraceae family, is traditionally used in Iran as anti-inflammatory, antimicrobial, antifungal, and sedative (
46,
47). In this study cytotoxic and apoptotic effects of different extracts were examined and compared on ACHN malignant cell line.